WJ22096 Tablets

· Nanjing Jingao biomidical technology Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WJ22096 Tablets, covering 2026-01-14 to 2026-01-14. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Clinical Study of WJ22096 Tablets in Patients With Advanced Tumors [Phase 1, Phase 2]